Clinical Trial Update: A Study to Learn How the Body Processes the Study Medicine Called Osivelotor (PF-07940367) in People With Loss of Liver Function [Phase 1]

View source ↗

Summary

A Phase 1 pharmacokinetic study in people with liver impairment to understand how Osivelotor is processed in the body. The trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Disease

Drugs mentioned

• Osivelotor (PF-07940367)

Snippet

Sponsor: Pfizer | Conditions: Liver Diseases | Phase 1 | Status: COMPLETED